Results 101 to 110 of about 291 (113)

Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats

European Journal of Pharmaceutical Sciences, 2022
Peter Thygesen
exaly  

Orphan designation: Somapacitan, Treatment of growth hormone deficiency

Case Medical Research, 2018
openaire   +2 more sources

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH

Journal of Clinical Endocrinology and Metabolism, 2023
Jun Mori, , Aristides Maniatis
exaly  

Somapacitan - Behebt den Mangel an Wachstumhormon

Österreichische Apothekerzeitung, 2022
openaire   +1 more source

Monitoring of weekly IGF-I levels during long-acting growth hormone therapy with somapacitan

Endocrine Abstracts, 2020
Kildemoes Rasmus Juul, Rasmussen Michael Højby, Henrik Agersø, Overgaard Rune Viig   +3 more
openaire   +1 more source

Somapacitan expected to provide IGF-I levels suitable for once-weekly dosing in children

Endocrine Abstracts, 2017
Rasmus Juul, Michael Rasmussen, Henrik Agerso, Rune Overgaard   +3 more
openaire   +1 more source

Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study

Endocrine Abstracts, 2019
Damholt Birgitte Bentz, Bendtsen Mette Dahl, Christian Hollensen, Rasmussen Michael Hojby   +3 more
openaire   +1 more source

Single Center Somapacitan Experience

Endocrine Practice
openaire   +1 more source

Le somapacitan (Sogroya®), une nouvelle hormone de croissance

Actualités Pharmaceutiques
Jacques Buxeraud, Sébastien Faure
openaire   +1 more source

Wachstumshormon Somapacitan zur einmal wöchentlichen Gabe verfügbar

Pädiatrie
openaire   +1 more source